Whether your personal interests are in supporting innovation, bringing lifesaving biomedical products to patients, training the next generation of biomedical leaders or fueling our economy, the Center for Biotechnology provides a vehicle to accomplish great things. Things that matter. Things that change, and save, lives.
Your involvement is an essential part of our future. Please consider a gift to the Center for Biotechnology which will help fuel innovation by ensuring that lifesaving technologies make it out of research labs and into the hands of patients.
Give to the Center for Biotechnology online through the Stony Brook Foundation. Contributions can be made to our Fund for Excellence. More information about donating through the Stony Brook Foundation can be found here.
Join as AdvaMed presents “Advancing Public Health with Wearables: Strategic Development of IoMT Biosensing Lifestyle Devices” with MIDI Medical Device Development Corp. and Valencell, Inc. This webinar is presented by Christopher Montalbano, CEO, MIDI Medical Device Development Corp., and Ryan Kraudel, Vice President, Marketing, Valencell, Inc., this webinar will examine the way in which wearables advance public health when a strategic device development approach is utilized to integrate and harmonize: Lifestyle, IoMT, Biosensing, and Physiological Sensing.
In this AdvaMed Event, MIDI & Valencell will cover: • Understand how wearable IoMT devices utilizing Bio-Sensors and Physiological Sensors translate into enhanced healthcare and wellness lifestyles. • Learn how to optimize the selection of sensor (or sensor cluster) through a proven 4-Step approach of: User Experience Monitoring, Body Assessments, Key Body Metric Capture and Sensor Selection. • Learn the 3-Step Innovation Roadmap™ for optimized wearable device development including: Discovery Research™, MVP R&D and AGILE Commercialization under ISO-13485. • Review of Case Studies that demonstrate implementation of these innovation principles yielding advanced wearable IoMT healthcare sensing devices.
Applications are now open for the 12th BioREACH Award Program from the Center for Biotechnology, which provides $50,000 in translational research funding for Stony Brook faculty and postdoctoral researchers to generate the evidence needed to advance promising innovations to the next stage of development.
BioREACH funds milestone-driven studies and welcomes biomedical innovations as well as platforms, tools, computational technologies, and other enabling technologies with the potential to contribute to solutions addressing unmet needs in health.
Application deadline: October 29, 2026, 5:00pm ET
For info sessions, eligibility and deadlines visit our REACH Website and FAQ.
The Center for Biotechnology (CfB) has helped advance some of Stony Brook University’s most impactful biomedical innovations, among them the yeast two-hybrid system, Xiaflex®, ReoPro®, Oracea®, and 3D virtual colonoscopy. The CfB has supported more than 475 faculty-led translational research projects and contributed to 306 license agreements generating $51 million in royalty returns to the University.
Questions? Reach out to our program contacts or sign up for office hours:
The Life Sciences Summit 2023 is returning to New York City - In Person - on October 11th at the Alexandria Center for Life Science. Save the date to join us in the fall and visit lifesciencessummit.org for program and registration updates.
[post_title] => Save the Date! Life Sciences Summit 2023 - October 11
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => save-the-date-life-sciences-summit-2023-october-11
[to_ping] =>
[pinged] =>
[post_modified] => 2024-12-03 12:27:34
[post_modified_gmt] => 2024-12-03 17:27:34
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://centerforbiotechnology.org/?p=4252
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 1450
[post_author] => 3
[post_date] => 2015-03-12 16:15:37
[post_date_gmt] => 2015-03-12 16:15:37
[post_content] => Symbiotic Health, Inc, a New York City based company and Center for Biotechnology client, was named "Best in Show" at the first of MABA's 1st Pitch Life Science events in 2015, Symbiotic Health has developed a capsule to help kill Clostridium difficile (Cdiff) infection which causes severe, debilitating diarrhea, is the most frequent hospital-acquired infection in the US and an immediate public health threat that requires urgent and immediate action (CDC). The company's pipeline includes a capsule microbiome therapeutic designed to cure Cdiff by restoring a community of protective bacteria.
Dr. Gerard Honig, CEO of Symbiotic Health, presented on behalf of the company. Stephen M. Goodman, Co-founder of Mid Atlantic Bio Angels and a partner at Pryor Cashman LLP in New York City, also a panelist at the event said Dr. Honig's pitch and responses to questions demonstrated both mastery of the competitive space and a willingness to address challenges to his analysis calmly and directly. His style, as well as his substance, exemplified the maxim that it's not just the business plan but the management that ultimately brings a company success. Read more about the company and the competition here.
[post_title] => Symbiotic Health Wins Best in Show at 1st Pitch Competition
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => symbiotic-health-wins-best-in-show-at-1st-pitch-competition
[to_ping] =>
[pinged] =>
[post_modified] => 2016-03-02 17:58:26
[post_modified_gmt] => 2016-03-02 17:58:26
[post_content_filtered] =>
[post_parent] => 0
[guid] => http://centerforbiotechnology.org/new/?p=1450
[menu_order] => 211
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 4406
[post_author] => 4
[post_date] => 2024-05-13 10:35:18
[post_date_gmt] => 2024-05-13 14:35:18
[post_content] =>
The Center for Biotechnology team would like to express our deepest condolences to the Simons Family on the recent passing of Jim Simons. His impact on both the Stony Brook University community, and around the world was immense, and this loss will be felt deeply. We are grateful for his tireless support of science, education, research and philanthropy.
Applications are now open for the 12th BioREACH Award Program from the Center for Biotechnology, which provides $50,000 in translational research funding for Stony Brook faculty and postdoctoral researchers to generate the evidence needed to advance promising innovations to the next stage of development.
BioREACH funds milestone-driven studies and welcomes biomedical innovations as well as platforms, tools, computational technologies, and other enabling technologies with the potential to contribute to solutions addressing unmet needs in health.
Application deadline: October 29, 2026, 5:00pm ET
For info sessions, eligibility and deadlines visit our REACH Website and FAQ.
The Center for Biotechnology (CfB) has helped advance some of Stony Brook University’s most impactful biomedical innovations, among them the yeast two-hybrid system, Xiaflex®, ReoPro®, Oracea®, and 3D virtual colonoscopy. The CfB has supported more than 475 faculty-led translational research projects and contributed to 306 license agreements generating $51 million in royalty returns to the University.
Questions? Reach out to our program contacts or sign up for office hours:
